Loading clinical trials...
Loading clinical trials...
Characterizing the Safety of [Carbon-11]Butanol and Estimating the Test-Retest Variance in Measurements of Its Whole Body Biokinetics Under Zero-Biological-Change Conditions
Conditions
Interventions
Carbon 11 Butanol
Locations
1
United States
Weill Cornell Medicine
New York, New York, United States
Start Date
September 17, 2020
Primary Completion Date
December 29, 2020
Completion Date
January 5, 2021
Last Updated
June 18, 2021
NCT04079179
NCT04880356
NCT05175417
NCT03514524
NCT07244900
NCT05175664
Lead Sponsor
Weill Medical College of Cornell University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions